Diabetes mellitus and lung function tests

الملخص EN

Objective : to measure the effects of type 1 and type 2 diabetes mellitus on the various Spiro metric pulmonary function tests Methods : this study involved 70 diabetic patients, 25 type 1 and 45 type 2 diabetes mellitus, and 45 control group.

Type 1 diabetic patients included 14 males and 11 females, their ages ranging from 17-63 years with their mean was 47.12, with SD12.83.

Type 2 diabetic patients included 26 males and 19 females ; their ages ranging from 19-63 years with their mean 46.67, with SD 9.50.

The control group involved 24 males and 21 females, their ages ranging from 13-68 years with their mean 38.78, with SD13.3.

The study was conducted in Ibn Sena Teaching Hospital Medical Outpatient Clinic, Al-wafa Medical Center in Mosul, and Mosul University-Medical Center.

Results : there were statistically significant differences between the control group and type 1 diabetes mellitus during the measurements of FVC %, FEV1 / FVC % and MMFR%, with statistically significant reductions in their values when compared to controls.

Furthermore, type 2 diabetes mellitus has significant effects on FVC %, FEV1 and FEV1 / FVC % when compared with the controls, with statistically significant differences from the control group.

There were no much differences between them apart from the FVC % which favors type 1 diabetes mellitus over type 2 diabetes mellitus with highly significant P-value.

Conclusion : The present study clearly indicates that both type 1 and type 2 diabetes mellitus adversely affects the various pulmonary function tests, and the results are in accord with other previous studies.